You are here

R&D

Drugmaker Lilly to trim workforce by nearly 9 percent

Yahoo/AP

Thu, 09/7/17 - 10:32 am

Bioverativ and Bicycle keep rare disease deals rolling

BioPharma Dive

Thu, 09/7/17 - 09:39 am

Bicycle Therapeutics

drug development

sickle cell disease

3SBio snaps up Therapure CDMO for $290M

BioPharma Dive

Wed, 09/6/17 - 09:27 am

drug development

Emboldened by recent R&D successes, Merck KGaA looks at selling off $1B-plus consumer division

Endpoints

Tue, 09/5/17 - 11:06 am

consumer health

Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract

Fierce Pharma

Fri, 09/1/17 - 06:53 pm

government contracts

InVivo retools to get Inspire trial back on track, lays off 39%

Mass Device

Wed, 08/30/17 - 09:52 am

spinal cord injury

Celgene Broadens Forma Deal, Adding $195M More for Drug R&D

Xconomy

Wed, 08/30/17 - 09:37 am

Forma Therapeutics

Allergan hits its already battered Irvine site with another round of job cuts

Fierce Pharma

Tue, 08/29/17 - 09:11 pm

Selecting Anti-Melanoma Drug Targets

Elsevier

Mon, 08/28/17 - 10:24 pm

Best Pharma Stocks Based on R&D Spending

Motley Fool

Mon, 08/28/17 - 09:27 am

Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events

Elsevier

Wed, 08/23/17 - 11:20 am

The sector’s most valuable unpartnered assets – up for grabs or on the shelf?

EP Vantage

Tue, 08/22/17 - 09:55 am

Portola Pharmaceuticals

DBV Technologies

Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert

Endpoints

Tue, 08/22/17 - 09:42 am

regenerative medicine

Struggling AstraZeneca ups the ante on mRNA pipeline work

Endpoints

Mon, 08/21/17 - 09:42 am

respiratory health

New target could yield treatment for Alzheimer's, ALS and more

Fierce Biotech

Thu, 08/17/17 - 09:57 am

drug development

Alzheimer's disease

The big revamp at GlaxoSmithKline R&D includes a new collaboration on AI

Endpoints

Wed, 08/16/17 - 10:23 am

artificial intelligence

Pharma companies, now marketing high-science drugs, rely more on medical affairs

Medical Marketing and Media

Tue, 08/8/17 - 11:13 pm

medical affairs

medical science liasons

Sanofi believes it’s still not too late to become a top player in cancer drug market

Endpoints

Tue, 08/8/17 - 11:16 am

GSK déjà vu: Time for a top-down switch as new CEO tries to conquer old R&D demons

Endpoints

Mon, 08/7/17 - 11:14 am

Sanofi shifts focus to internal R&D as it preps an end to a stunningly effective Regeneron alliance

Endpoints

Thu, 08/3/17 - 11:19 am

drug development

Pages